Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF®, a Phase II randomised, double-blind, placebo-controlled, dose-finding study

By sjmartinez • September 11, 2024

Chalmers JD, Shteinberg M, Mall MA, O'Donnell AE, Watz H, Gupta A, Frahm E, Eleftheraki A, Rauch J, Chotirmall SH, Armstrong AW, Eickholz P, Hasegawa N, Sauter W, McShane PJ. Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF®, a Phase II randomised, double-blind, placebo-controlled, dose-finding study. Eur Respir J. 2024 Sep 10:2401551. doi: 10.1183/13993003.01551-2024. Epub ahead of print. PMID: 39255990.

Tags: Dermatology, Publications

Safety and Efficacy of envudeucitinib, a highly selective, oral allosteric TYK2 inhibitor, in patients with moderate-to-severe plaque psoriasis: Results from the 52-week open-label extension period of the Phase 2 STRIDE study

Papp KA, Jacobs S, Sofen H, Bukhalo M, Muscianisi E, Ma G, Lau G, Bettinger M, Rubio RG, Hitraya E, Blauvelt A; Open-Label Extension study[...]

Differentially Expressed Salivary miRNAs in Temporomandibular Disorders

Kaczor-Urbanowicz KE, Aziz M, Wilhalme H, Aronovich S, Hatfield ER, Aghaloo T, Arman S, Mohammadi A, Husain M, Tetradis S, Elashoff D, Pellegrini M, Wong[...]

Neurotrophic Tyrosine Receptor Kinase-Rearranged Spindle Cell Neoplasm Presenting on the Breast of a 44-Year-Old Woman

Saka F, McKenzie S, Milani-Nejad N, Smart C. Neurotrophic Tyrosine Receptor Kinase-Rearranged Spindle Cell Neoplasm Presenting on the Breast of a 44-Year-Old Woman. Am J[...]